SANFILIPPO JOHN B & SON INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SANFILIPPO JOHN B & SON INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	847	889	876	880	858	956	1,000	1,067	1,107	1,176
Cost of revenue	705	750	718	704	673	756	788	853	904	964
Gross profit	142	139	158	176	185	200	212	214	203	211
Research and development	0.66	0.7	0.89	1	2	2.83	3.36	3.62	3.49	3.33
General and administrative	32.1	29.8	38	37.9	36.8	37.7	44.6	48.5	39.8	43
Operating expenses	81.4	82.7	99.7	97.2	99.8	112	121	129	119	122
Operating income	60.5	56.2	58.5	78.5	85.2	87.4	90.2	85.2	84.7	89.2
Interest expense	2.91	3.46	3.06	2.01	1.44	1.92	2.16	2.55	3.55	2.43
Other non-operating income	-6.34	-6.84	-6.1	-5.84	-5.36	-5.74	-4.87	-5.25	-6.85	-6.22
Pre-tax income	54.1	49.4	52.4	72.7	79.8	81.7	85.4	79.9	77.9	83
Income tax	18	16.9	13	18.6	20.1	19.9	22.5	19.7	18.9	21
Net income	36.1	32.5	39.5	54.1	59.7	61.8	62.9	60.2	58.9	61.9
EBITDA	76	71.6	75.6	96.5	103	106	111	110	112	117
EPS, basic	3.19	2.86	3.45	4.72	5.19	5.36	5.43	5.19	5.06	5.29
EPS, diluted	3.17	2.84	3.43	4.69	5.17	5.33	5.40	5.15	5.03	5.26
Shares, basic (weighted)	11.3	11.4	11.4	11.5	11.5	11.5	11.6	11.6	11.7	11.7
Shares, diluted (weighted)	11.4	11.4	11.5	11.5	11.6	11.6	11.6	11.7	11.7	11.8
Dividend per share	5.00	2.50	2.55	6.00	5.00	3.00	4.75	3.00	2.10	4.00

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	1.96	1.45	1.59	1.54	0.67	0.42	1.95	0.48	0.59	1.15
Receivables	64.8	65.4	61	57	66.3	69.6	72.7	85	76.7	84.3
Inventory	182	174	157	172	148	205	173	197	255	246
Other current assets	4.17	6.65	5.75	8.32	8.57	8.28	6.81	12.1	14.6	18
Total current assets	253	248	225	239	225	283	254	294	346	349
Property, plant and equipment	125	125	126	124	133	133	135	165	178	256
Lease right-of-use assets			0	4.35	3.48	2.3	6.43	27.4	27.8	24.6
Goodwill		9.65	9.65	9.65	9.65	9.65	11.8	11.8	11.8	11.8
Intangible assets	0	17.7	14.6	12.1	9.96	8.07	6.66	5.82	4.43	3.39
Total assets	398	416	391	407	398	447	425	516	598	659
Accounts payable	50	60.3	42.6	36.3	48.9	47.7	42.7	53.4	60.5	72.4
Accrued liabilities	16	6.42	22.1	25.6	24.1	18.9	27.6	35.6	18.4	34.7
Short-term debt	3.42	7.17	7.34	5.29	3.88	3.15	0.67	0.74	0.94	6.05
Total current liabilities	110	117	83.9	112	100	123	85.7	126	156	168
Long-term debt	25.2	27.4	20.4	14.7	10.9	7.77	7.1	6.37	14.6	43.6
Lease liabilities			0	2.99	2.1	1.08	4.77	24.9	24.2	20.6
Other non-current liabilities	6.51	7.01	7.73	7.76	7.88	0.38	1.55	1.95	3.55	6.64
Total liabilities	163	173	137	169	156	168	133	193	237	279
Total debt	28.6	34.5	27.7	20	14.7	10.9	7.77	7.1	15.5	49.6
Paid-in capital	118	120	122	124	126	129	132	136	140	144
Retained earnings	123	127	138	124	126	154	162	187	221	237
Treasury stock	-1.2	-1.2	-1.2	-1.2	-1.2	-1.2	-1.2	-1.2	-1.2	-1.2
Other comprehensive income	-4.4	-3.18	-4.33	-8.63	-9.03	-2.48	-0.2	1.04	0.56	0.84
Shareholders' equity	235	243	255	238	242	279	292	323	361	380
Total equity	235	243	255	238	242	279	292	323	361	380
Total liabilities and equity	398	416	391	407	398	447	425	516	598	659

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	36.1	32.5	39.5	54.1	59.7	61.8	62.9	60.2	58.9	61.9
Depreciation and amortization	15.6	15.4	17	17.9	18.3	18.3	20.5	24.6	26.9	28.2
Stock-based compensation	2.5	2.8	2.64	2.47	2.91	3.57	3.57	4.39	4.52	4.21
Deferred income tax	-1.74	3.66	-0.3	0.1	0.84	0.55	-1.12	-0.7	-2.49	8.13
Change in receivables	13.2	1.75	4.45	4.02	-9.39	-3.28	-3.12	-12.1	8.34	-7.77
Change in inventory	-25.8	10	17.3	-15	24.1	-56.9	32.2	11.9	-58	8.77
Change in payables	6.38	8.88	-17	-6.72	11.4	-0.09	-5.04	10.6	6.84	4.11
Cash from operations	52.7	66.2	83.5	63.6	105	19.6	125	102	30.5	124
Capital expenditures	-10.9	-13.2	-15.1	-15	-25.2	-17.8	-20.7	-28.3	-50.7	-88.1
Acquisitions		-21.7			0	0	-3.5	-59	0	0
Cash from investing	-10.5	-35	-14.6	-14	-23	-11.4	-24.3	-87.3	-50.8	-86.2
Debt issued							0	0	9.27	35
Stock issued	0.06	0.02	0	0	0	0
Dividends paid	-56.5	-28.4	-29.1	-68.7	-57.5	-34.5	-54.9	-34.8	-24.4	-46.8
Cash from financing	-42.4	-31.7	-68.7	-49.6	-82.6	-8.49	-98.8	-15.8	20.4	-37.1
Net change in cash	-0.27	-0.51	0.14	-0.06	-0.86	-0.26	1.53	-1.46	0.1	0.56
Free cash flow	41.8	52.9	68.4	48.6	79.5	1.85	104	73.4	-20.2	35.7
Interest paid	2.76	3.36	2.87	1.95	1.32	1.74	2.12	2.37	3.29	2.46
Income taxes paid	17.6	15.8	10.9	14.4	22	21.3	23.4	22.1	21.2	13.9

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $67.24 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	18.0%	Gross profit / revenue.
Operating margin	7.6%	Operating income / revenue.
EBITDA margin	10.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.1%	Pre-tax income / revenue.
Net margin	5.3%	Net income / revenue.
FCF margin	3.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.5%	Cash from operations / revenue.
Effective tax rate	25.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	16.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.9%	Net income / average total assets.
Return on invested capital (ROIC)	16.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.3%	Research and development expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	7.5%	Capital expenditures / revenue.
D&A / revenue	2.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	5.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	0.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	2.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	2.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	5.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-0.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	0.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	4.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-0.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	0.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	305.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-0.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-29.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-14.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	90.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-5.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-4.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	5.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	15.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.08x	Current assets / current liabilities.
Quick ratio	0.51x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.01x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.13x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	7.5%	Total debt / total assets.
Liabilities / assets	42.3%	Total liabilities / total assets.
Net debt	$48.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.41x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	36.7x	Operating income / interest expense.
Working capital	$181.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	2.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$364.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.87x	Revenue / average total assets.
Fixed asset turnover	5.42x	Revenue / average property, plant and equipment.
Inventory turnover	3.85x	Cost of revenue / average inventory.
Days inventory	95 days	365 x average inventory / cost of revenue.
Receivables turnover	14.6x	Revenue / average receivables.
Days sales outstanding	25 days	365 x average receivables / revenue.
Days payables	25 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	95 days	Days inventory + days sales outstanding - days payables.
FCF conversion	57.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	71.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.26	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$5.29	Net income per basic share, as reported (split-adjusted).
Revenue per share	$99.82	Revenue / diluted weighted shares.
FCF per share	$3.04	Free cash flow / diluted weighted shares.
Operating cash flow per share	$10.51	Cash from operations / diluted weighted shares.
Book value per share	$32.26	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$30.98	Tangible book value / shares outstanding.
Cash per share	$0.10	(Cash + short-term investments) / shares outstanding.
Dividend per share	$4.00	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	75.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	130.8%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$786.0M	Share price x shares outstanding.
Enterprise value	$834.5M	Market cap + total debt - cash - short-term investments.
P/E	12.7x	Market cap / net income. Only when net income is positive.
P/S	0.67x	Market cap / revenue.
P/B	2.07x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.15x	Market cap / tangible book value, when positive.
P/FCF	22.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.35x	Market cap / cash from operations, when positive.
EV/Sales	0.71x	Enterprise value / revenue.
EV/EBIT	9.36x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.11x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.5%	Free cash flow / market cap.
Earnings yield	7.9%	Net income / market cap (the inverse of P/E).
Dividend yield	5.9%	Dividends paid over the period / market cap.
Shareholder yield	5.9%	(Dividends paid + share buybacks) / market cap.

What was SANFILIPPO JOHN B & SON INC's revenue in fiscal 2026?

SANFILIPPO JOHN B & SON INC reported revenue of $1.18B for fiscal 2026, 6.2% higher than the year before.

Was SANFILIPPO JOHN B & SON INC profitable in fiscal 2026?

Yes. Net income was $61.9M, a net margin of 5.3%.

How much free cash flow did SANFILIPPO JOHN B & SON INC generate in fiscal 2026?

Cash from operations of $123.8M minus capital expenditures of $88.1M left free cash flow of $35.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SANFILIPPO JOHN B & SON INC